Clinical Trials Logo

Thyroid Adenoma clinical trials

View clinical trials related to Thyroid Adenoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01433809 Completed - Thyroid Cancer Clinical Trials

Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm

Start date: June 2011
Phase: N/A
Study type: Observational

This protocol will evaluate microRNA biomarkers in blood and fine-needle aspirate biopsies (FNAB) of thyroid nodules. MicroRNA profiles will be determined and evaluated for their utility in pre-operative diagnosis, in particular to distinguish benign from malignant throid neoplasms. Post-surgical fresh-frozen thyroid cancer tissue will be assessed for somatic mutations, mRNA, and microRNA expression patterns. FFPE tissue will be used to obtain H&E and unstained slides to specific biomarker results using immunohistochemistry.